Note some links may be broken where content has subsequently been removed, and pages may have had further updates since those listed below.
|
18 December 2019 |
Information on clozapine monitoring updated. |
revision 2019.079 |
|
17 December 2019 |
Immunology updates to ANA screen, ANA (Hep2 method), dsDNA antibody, ENA antibody, ANCA, GBM antibody, liver antibodies, anti-phospholipid antibodies, intrinsic factor antibody and tTG antibody. |
revision 2019.078 |
|
16 December 2019 |
Update to ethylene glycol and methanol referral laboratory and turnaround time. |
revision 2019.077 |
|
10 December 2019 |
Addition of time limit for analysis of samples for ESR. |
revision 2019.076 |
|
4 December 2019 |
Temporary changes to mumps molecular testing due to supplier issues. |
revision 2019.075 |
|
3 December 2019 |
Blood film added. |
revision 2019.074 |
|
revision 2019.073 |
||
|
18 November 2019 |
revision 2019.072 |
|
|
13 November 2019 |
Update to UKAS accreditation statements. |
revision 2019.071 |
|
30 October 2019 |
Update to plasma viscosity and G6PD screen. |
revision 2019.070 |
|
29 October 2019 |
Update to blood mercury and addition of urine mercury. |
revision 2019.069 |
|
21 October 2019 |
Addition of turnaround time for faecal occult blood (FIT/FOB test). |
revision 2019.068 |
|
12 October 2019 |
From Monday 7 October, the first-line investigation for ANCA-associated vasculitis will be MPO and PR3 antibody. ANCA immunofluorescence will only be performed when MPO and PR3 antibody are positive, in line with international consensus guidelines. See ANCA for details. |
revision 2019.067 |
|
New referral guidance for calprotectin (faeces) from 18/10/19. |
revision 2019.066 |
|
|
11 October 2019 |
Further updates to Virology/ Serology content. |
revision 2019.065 |
|
8 October 2019 |
Virology/ Serology amendments to upper/lower respiratory tract infection (diagnostic virology), legionellosis and cryptococcal antigen. |
revision 2019.064 |
|
7 October 2019 |
Amendment to sample type for methotrexate. |
revision 2019.063 |
|
From 23rd September 2019, changes at referral lab for infliximab and adalimumab are giving higher results - see listings for updated reference ranges. |
revision 2019.062 |
|
|
6 October 2019 |
New Virology/ Serology content added: ACE (adenovirus/ CMV/ EBV) PCR, aspergillus / galactomannan testing, avian allergens (avian precipitins), beta-glucan antigen testing, BK virus, body fluid exposure – virology screening, Bordetella pertussis antibody, Chlamydia group serology (psittacosis), CMV (cytomegalovirus) serology, EBV (Epstein-Barr virus) serology, enterovirus detection, eye infection molecular detection, Farmer's lung, fungal allergens (fungal precipitins), gastroenteritis PCR, HCV resistance testing, Helicobacter antibody testing, hepatitis A serology, hepatitis B immunity / vaccination, hepatitis B serology & viral load testing, hepatitis C serology & viral load testing, hepatitis C virus core antigen serology, hepatitis delta (HDV) testing, hepatitis E (HEV) testing, Histoplasma antibody testing, HIV 1 proviral DNA testing, HIV serology, HIV viral load & resistance testing, HSV molecular detection, HTLV serology, human herpes 8 (HHV8) serology, JC virus testing, Lyme serology (borreliosis), measles serology, meningococcal & pneumococcal detection, mumps serology, Mycoplasma & Ureaplasma PCR, Mycoplasma genitalium detection, Mycoplasma pneumoniae serology, parvovirus B19 serology. Q fever, rabies serology, rubella serology, syphilis serology, toxoplasma (toxoplasmosis), tropical parasite serology, tropical virus serology, vaccine immunity testing, VZV (varicella-zoster virus) serology, Whipple Disease molecular detection. |
revision 2019.061 |
|
30 September 2019 |
Update to G6PD screen. |
revision 2019.060 |
|
29 September 2019 |
Updates to Chlamydia trachomatis/ Neisseria gonorrhoeae test, genital ulcer - diagnostic virology and baseline serology for Haematology/Oncology patients. |
revision 2019.059 |
|
25 September 2019 |
Addition of BD neonatal tube information to sample requirements. |
revision 2019.058 |
|
23 September 2019 |
Update to procalcitonin turnaround time, and addition of clinical cut-offs. | revision 2019.057 |
|
10 September 2019 |
Amendment to heparin assay (Anti-Xa) - Danaparoid (Orgaran) no longer routinely in use. | revision 2019.056 |
| New links added on dropdown menus to full test listings in Biochemistry & Immunology, Haematology & Transfusion, and Microbiology & Infection. | revision 2019.055 | |
| Test information added to Kleihauer test. | revision 2019.054 | |
|
3 September 2019 |
Updates to haematology contact numbers. |
revision 2019.053 |
|
Pathology Ordering and Results System (ICE) – Scheduled Downtime 8th September 2019 Radiology results can be accessed using PACS. For further information please email |
revision 2019.052 |
|
|
2 September 2019 |
Remove paediatric range for reticulocytes. |
revision 2019.051 |
|
27 August 2019 |
Amended turnaround times for potassium channel antibody, LGI1 and CASPR2. |
revision 2019.050 |
|
The Oxford Immunology referral laboratory have changed the method used to perform the western blot for neuronal antibodies as of 29th July 2019. Anti-Ma1 will no longer be reported and both Anti-Titin and Anti-Recoverin have been added to the panel. Results will now be reported as negative, equivocal or positive. |
revision 2019.049 |
|
|
13 August 2019 |
Sarah Bastow is the new Frontier Head of Service for Blood Sciences. |
revision 2019.048 |
| Turnaround times for infliximab and adalimumab amended. |
revision 2019.047 |
|
|
23 July 2019 |
Update to levetiracetam sample type - default is now EDTA blood. |
revision 2019.046 |
|
23 July 2019 |
Change to faecal occult blood (FIT) sampling with introduction of FIT kits. |
revision 2019.045 |
|
9 July 2019 |
Update of Environmental Microbiology Unit content. |
revision 2019.044 |
|
2 July 2019 |
Referrral laboratory has informed us of amended turnaround times for neuronal antibodies, potassium channel antibody, calcium channel antibody and MuSK antibody. |
revision 2019.043 |
|
Addition of HLA typing for disease association and T-Cell gene rearrangement |
revision 2019.042 |
|
|
1 July 2019 |
Addition of reference range sources for FBC, ESR, haemoglobinopathy screen and reticulocytes. |
revision 2019.041 |
|
Expansion of information on transporting samples via pneumatic pods to cover prohibited high risk samples. |
revision 2019.040 |
|
|
20 June 2019 |
The CTX assay is being discontinued in-house from the end of June 2019. The same sample will be used for the alternative bone marker procollagen I (P1NP) - if CTX is specifically required please contact the Duty Biochemist before sending the sample. |
revision 2019.039 |
|
19 June 2019 |
Due to equipment failure we currently have no in-house ethylene glycol or methanol service; samples will be sent to referral laboratories as necessary. |
revision 2019.038 |
|
18 June 2019 |
The live cell assay for NMDA receptor antibodies is not currently available. |
revision 2019.037 |
|
Addition of request for travel history to help aid diagnosis with malarial parasites. |
revision 2019.036 |
|
|
11 June 2019 |
Change to female alpha galactosidase cut off for Fabry screen. |
revision 2019.035 |
|
5 June 2019 |
Update to UKAS accreditaion information for Microbiology & Infection. |
revision 2019.034 |
|
4 June 2019 |
The Microbiology and Virology/Serology pages have been reviewed and updated as necessary to reflect current practice. |
revision 2019.033 |
|
29 May 2019 |
Change to CSF ACE reference range and units from 1.6.2019 due to change of provider at referral laboratory - new reference range will be 0 - 1.20 µM/min/L and the new turnaround time 14 working days. |
revision 2019.032 |
| Change to 5-HIAA reference range from 1.6.2019 due to change of provider at referral laboratory - new reference range will be < 47 µmol/24h. |
revision 2019.031 |
|
|
21 May 2019 |
Lipoprotein (a) added. |
revision 2019.030 |
|
20 May 2019 |
Correction to lower limit of male CK range. |
revision 2019.029 |
|
Procollagen I (P1NP) added. |
revision 2019.028 |
|
|
8 May 2019 |
CART is no longer part of routine gut hormone profile. Please specify on request form if required. |
revision 2019.027 |
|
23 April 2019 |
Update of Histopathology page (referral laboratories, contacts). |
revision 2019.026 |
|
17 April 2019 |
Addition of instructions to CSF collection and CSF xanthochromia specifying need to deliver samples to Clinical Biochemistry immediately and importance of light-protection. |
revision 2019.025 |
|
15 April 2019 |
Correction to new selenium reference ranges. |
revision 2019.024 |
|
8 April 2019 |
Amended sample requirement for lupus anticoagulant and thrombophilia screen. |
revision 2019.023 |
|
2 April 2019 |
Paediatric (Tanner stage) ranges added to LH and FSH. |
revision 2019.022 |
|
26 March 2019 |
Instrinsic factor antibody is being done in-house. |
revision 2019.021 |
|
13 March 2019 |
Addition of sample collection information to sweat testing. |
revision 2019.020 |
| Removal of outdated form for requesting access to pathology laboratories. |
revision 2019.019 |
|
| Sample/ supplies information added to electron micsoscopy content. |
revision 2019.018 |
|
| New chain of evidence form for SaSH users. |
revision 2019.017 |
|
| New email address for Pathlinks - Pathology IT content and downloads updated. |
revision 2019.016 |
|
| Update to Heparin-induced thrombocytopenia test |
revision 2019.015 |
|
|
5 March 2019 |
Addition of UKAS statement to Pathology home page, and associated update to general information. |
revision 2019.014 |
|
26-7 February 2019 |
New reference range for factor XIII (in-house from 1.3.19). |
revision 2019.013 |
|
Addition of reference range source to in-house coagulation tests: APTT ratio, coagulation factor assays, coagulation screen, D-dimers, lupus anticoagulant, PT inhibitor screen (50:50 mix), reptilase time, thrombin time, thrombophilia screen. |
revision 2019.012 |
|
|
25-26 February 2019 |
Updated reference ranges for referred metals: arsenic, copper (urine), manganese, mercury, selenium and thallium. |
revision 2019.011 |
|
25 February 2019 |
Addition of MPL mutation to site. |
revision 2019.010 |
|
21 February 2019 |
New ranges for von Willebrand avtivity. |
revision 2019.009 |
|
New revision of Instructions for Collecting Samples for Chain of Evidence Toxicology Analysis in Hospital Patients. |
revision 2019.008 |
|
|
11 February 2019 |
New reference range and turnaround time for lamotrigine due to changes at referral laboratory. |
revision 2019.007 |
|
6 February 2019 |
Down's, Edwards’ and Patau’s syndrome screening - update to second trimester screening content. |
revision 2019.006 |
|
5 February 2019 |
Update to selenium sample requirement - referral lab no longer accepts samples in gel-containing (gold cap) tubes. |
revision 2019.005 |
|
15 January 2019 |
Updates to interferences for AST and ALT (isoniazid and furosemide do not interfere), and B12 (hyperproteinaemic samples are not suitable). |
revision 2019.004 |
|
14 January 2019 |
Updates to lymphocyte subsets (B, T, NK cell counts) and CD4/8 counts (T lymphocyte subsets) | revision 2019.003 |
| Updates to ethylene glycol and methanol. | revision 2019.002 | |
| Update to test information for voriconazole. | revision 2019.001 |